Price Associates, Inc., Bar Harbor, ME, United States.
Crit Rev Toxicol. 2022 Apr;52(4):317-324. doi: 10.1080/10408444.2022.2082919. Epub 2022 Jul 19.
Historically, mesothelioma, which is almost exclusively a cancer of the pleura or peritoneum, has been referred to as a sentinel disease for asbestos exposure meaning that the disease is an epidemiologic marker for asbestos. This description of mesothelioma often has been misinterpreted to mean that the only risk factor for mesothelioma is asbestos. In addition to a few risk factors other than asbestos, in the US, background mesotheliomas, i.e. mesothelioma cases that are a consequence of spontaneous tumor formation, are the most prevalent number of cases after asbestos-associated cases. My analysis of SEER data for 1973 through 2005 published in 2009 projected that around 2040 virtually all mesothelioma cases in the US will be background cases. The update here, which is based on the most current SEER data, 1975 through 2018, and the same methods used in 2009 shows that the pattern of mesothelioma incidence is unchanged. Further, in general agreement with the analysis published in 2009, after 2040 virtually all mesothelioma cases, currently estimated to be approximately 1600 per year, will be background cases.
从历史上看,间皮瘤几乎完全是胸膜或腹膜的癌症,被称为石棉暴露的“哨兵疾病”,这意味着这种疾病是石棉的流行病学标志物。这种对间皮瘤的描述常常被误解为间皮瘤的唯一危险因素是石棉。除了石棉以外的少数几个危险因素外,在美国,背景性间皮瘤,即由自发性肿瘤形成引起的间皮瘤病例,是石棉相关病例之后最常见的病例数量。我在 2009 年发表的对 1973 年至 2005 年 SEER 数据的分析预测,到 2040 年左右,美国几乎所有的间皮瘤病例都将是背景性病例。此处的更新基于最新的 SEER 数据(1975 年至 2018 年),并使用了与 2009 年相同的方法,表明间皮瘤发病率的模式没有变化。此外,与 2009 年发表的分析结果基本一致,在 2040 年之后,目前估计每年约有 1600 例间皮瘤病例将成为背景性病例。